| Alice Byrd Tawes Nursing Home | |
| 201 Hall Highway, Crisfield, Maryland 21817 | |
| (410) 968-1200 | |
| Name | Alice Byrd Tawes Nursing Home |
|---|---|
| Location | 201 Hall Highway, Crisfield, Maryland |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 76 |
| Occupancy Rate | 79.34% |
| Medicare ID (CCN) | 215058 |
| Legal Business Name | Mccready Foundation Inc |
| Ownership Type | Non Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported that patient enrollment and dosing in the Phase II trial of its long-acting version of human growth hormone (hGH-CTP) are proceeding according to plan, with study completion targeted for mid-year 2011.
In a pilot study assessing the effect of different levels of chloride in intravenous fluids administered to critically ill patients in an intensive care unit, restricting the amount of chloride administration was associated with a significant decrease in the incidence of acute kidney injury and the use of renal replacement therapy, according to a study in the October 17 issue of JAMA.
Mental health problems such as Post-Traumatic Stress Disorder, anxiety and depression are common among healthcare staff during and immediately after pandemics – according to new research from the University of East Anglia.
The risk of death resulting from heart attack is higher in people with schizophrenia than in the general public, according to scientists at the Centre for Addiction and Mental Health (CAMH) and the Institute for Clinical Evaluative Sciences (ICES).
BioMimetic Therapeutics, Inc., a biotechnology company specializing in the development and commercialization of innovative bioactive products to promote the healing of musculoskeletal injuries and diseases, today reported its financial results as of and for the three and nine months ended September 30, 2011.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $10286 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 26.85 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 1.85 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 49.44 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.5 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.75 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 21.72 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.61 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 88.55 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 19.64 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 84.55 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.27 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 43.13 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 5.91 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 0.71 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.63 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 68.55 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 92.65 | 82.93 |
News Archive
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported that patient enrollment and dosing in the Phase II trial of its long-acting version of human growth hormone (hGH-CTP) are proceeding according to plan, with study completion targeted for mid-year 2011.
In a pilot study assessing the effect of different levels of chloride in intravenous fluids administered to critically ill patients in an intensive care unit, restricting the amount of chloride administration was associated with a significant decrease in the incidence of acute kidney injury and the use of renal replacement therapy, according to a study in the October 17 issue of JAMA.
Mental health problems such as Post-Traumatic Stress Disorder, anxiety and depression are common among healthcare staff during and immediately after pandemics – according to new research from the University of East Anglia.
The risk of death resulting from heart attack is higher in people with schizophrenia than in the general public, according to scientists at the Centre for Addiction and Mental Health (CAMH) and the Institute for Clinical Evaluative Sciences (ICES).
BioMimetic Therapeutics, Inc., a biotechnology company specializing in the development and commercialization of innovative bioactive products to promote the healing of musculoskeletal injuries and diseases, today reported its financial results as of and for the three and nine months ended September 30, 2011.
› Verified 5 days ago
Alice Byrd Tawes Nursing Home Location: 201 Hall Highway, Crisfield, Maryland 21817 Phone: (410) 968-1200 |